secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2021-10-27T23:59:59+00:00
Accession:  0001193125-21-308673
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics appoints Gary Winer and Lisa Giles to board of directors
----------------------------------------------------------------------

- HCW Biologics appointed Gary Winer as Class I director and Lisa Giles as Class II director, effective Oct 25, 2021.
- Both new directors appointed to audit and compensation committees; Dr. Hing Wong stepped down from audit committee.
- Winer was CEO of ORGENTEC Diagnostika until Sept 2021; Giles is founder/CEO of Giles & Associates Consultancy.
- Directors compensated per Non-Employee Director Compensation Policy, pro-rated; indemnification agreements to be signed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/d53143d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-308673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer